Insufficient scRNA-seq data for expression of TNIP3 at single-cell level.
Insufficient scRNA-seq data for expression of TNIP3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 99% | 172.01 | 575 / 578 | 66% | 3.47 | 765 / 1155 |
spleen | 100% | 49.64 | 240 / 241 | 0% | 0 | 0 / 0 |
intestine | 60% | 30.62 | 584 / 966 | 38% | 0.98 | 201 / 527 |
stomach | 58% | 22.43 | 207 / 359 | 39% | 1.19 | 112 / 286 |
lymph node | 0% | 0 | 0 / 0 | 86% | 7.08 | 25 / 29 |
esophagus | 27% | 17.69 | 397 / 1445 | 52% | 2.13 | 95 / 183 |
tonsil | 0% | 0 | 0 / 0 | 76% | 5.93 | 34 / 45 |
bladder | 48% | 7.71 | 10 / 21 | 24% | 1.14 | 123 / 504 |
peripheral blood | 69% | 62.57 | 645 / 929 | 0% | 0 | 0 / 0 |
uterus | 31% | 3.70 | 52 / 170 | 36% | 1.42 | 163 / 459 |
breast | 41% | 6.40 | 187 / 459 | 16% | 0.57 | 179 / 1118 |
skin | 34% | 12.63 | 617 / 1809 | 22% | 0.56 | 105 / 472 |
kidney | 29% | 3.97 | 26 / 89 | 26% | 0.84 | 235 / 901 |
adipose | 55% | 35.91 | 662 / 1204 | 0% | 0 | 0 / 0 |
prostate | 44% | 9.52 | 109 / 245 | 1% | 0.02 | 5 / 502 |
thymus | 38% | 7.72 | 250 / 653 | 6% | 0.17 | 38 / 605 |
liver | 37% | 6.65 | 84 / 226 | 4% | 0.17 | 16 / 406 |
brain | 38% | 7.27 | 994 / 2642 | 1% | 0.03 | 10 / 705 |
ovary | 14% | 1.98 | 26 / 180 | 18% | 0.59 | 79 / 430 |
adrenal gland | 28% | 5.71 | 73 / 258 | 3% | 0.09 | 8 / 230 |
blood vessel | 29% | 4.22 | 383 / 1335 | 0% | 0 | 0 / 0 |
pancreas | 8% | 0.77 | 27 / 328 | 11% | 0.19 | 19 / 178 |
heart | 16% | 4.04 | 135 / 861 | 0% | 0 | 0 / 0 |
muscle | 2% | 0.17 | 18 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_0002756 | Biological process | MyD88-independent toll-like receptor signaling pathway |
GO_0006954 | Biological process | inflammatory response |
GO_0043124 | Biological process | negative regulation of canonical NF-kappaB signal transduction |
GO_0034142 | Biological process | toll-like receptor 4 signaling pathway |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0005829 | Cellular component | cytosol |
GO_0031593 | Molecular function | polyubiquitin modification-dependent protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | TNIP3 |
Protein name | TNFAIP3-interacting protein 3 (A20-binding inhibitor of NF-kappa-B activation 3) (ABIN-3) (Listeria-induced gene protein) TNFAIP3-interacting protein 3 beta TNFAIP3 interacting protein 3 |
Synonyms | LIND ABIN3 |
Description | FUNCTION: Binds to zinc finger protein TNFAIP3 and inhibits NF-kappa-B activation induced by tumor necrosis factor, Toll-like receptor 4 (TLR4), interleukin-1 and 12-O-tetradecanoylphorbol-13-acetate. Overexpression inhibits NF-kappa-B-dependent gene expression in response to lipopolysaccharide at a level downstream of TRAF6 and upstream of IKBKB. NF-kappa-B inhibition is independent of TNFAIP3 binding. . |
Accessions | ENST00000509841.1 [Q96KP6-3] ENST00000515036.1 H0Y9J7 ENST00000057513.8 [Q96KP6-1] ENST00000507879.5 [Q96KP6-2] Q96KP6 A5HU65 |